Braegen-05

N/A

Report date: 2025/10/15 15:52:41
NME

Base Information

Drug NameBraegen-05
Drug Alias NameBraegen-05
ClassificationSmall molecules
Mechanisms of ActionSynuclein alpha modulators
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson DiseaseLewy Body DiseaseMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen Braegen Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Braegen Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson DiseaseLewy Body DiseaseMultiple System Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A